Showing results (361-370 of 2,338) with videos related to

Sort By:
Pageof 234
Clinical Lung Cancer|November 7, 2020
A Phase I/II Study of Biweekly Carboplatin and Nab-paclitaxel With Concurrent Radiotherapy for Patients With Locally Advanced Unresectable Stage III Non-small-cell Lung CancerHisashi Tanaka, Yukihiro Hasegawa, Tomonori Makiguchi, et al.
Clinical Lung Cancer|November 7, 2020
A Phase II Trial of Nivolumab With Chemotherapy Followed by Maintenance Nivolumab in Patients With Pleural Mesothelioma After Surgery: The NICITA Study ProtocolRajiv Shah, Laura V Klotz, Inn Chung, et al.
Clinical Lung Cancer|September 11, 2020
Oncologic Outcomes of Surgery Versus SBRT for Non-Small-Cell Lung Carcinoma: A Systematic Review and Meta-analysisMichiel A Ijsseldijk, Melina Shoni, Charles Siegert, et al.
Clinical Lung Cancer|September 3, 2020
The Role of Postoperative Radiation Therapy for pN2 Non-small-cell Lung CancerNikhil P Mankuzhy, Muayad F Almahariq, Zaid A Siddiqui, et al.
Clinical Lung Cancer|November 14, 2020
Real-World Effectiveness of Nivolumab Monotherapy After Prior Systemic Therapy in Advanced Non-Small-Cell Lung Cancer in the United StatesDavid D Stenehjem, Solomon J Lubinga, Komal Gupte-Singh, et al.
Clinical Lung Cancer|November 15, 2020
Clinical and Imaging Features of Non-Small-Cell Lung Cancer in Young PatientsSherief H Garrana, Ibiayi Dagogo-Jack, Rosemary Cobb, et al.
Clinical Lung Cancer|February 25, 2020
Locoregional Control, Overall Survival, and Disease-Free Survival in Stage IIIA (N2) Non-Small-Cell Lung Cancer: Analysis of Resected and Unresected PatientsRavi Rajaram, Arlene M Correa, Ting Xu, et al.
Clinical Lung Cancer|February 25, 2020
Performance Status and Age as Predictors of Immunotherapy Outcomes in Advanced Non-Small-Cell Lung CancerTamjeed Ahmed, Thomas Lycan, Andy Dothard, et al.
Clinical Lung Cancer|February 28, 2020
Prognostic Impact of Programmed Death-ligand 1 and Surrounding Immune Status on Stage I Lung CancerYoshinori Handa, Yasuhiro Tsutani, Noriyuki Shiroma, et al.
Clinical Lung Cancer|March 12, 2018
Atezolizumab in Japanese Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer: A Subgroup Analysis of the Phase 3 OAK StudyToyoaki Hida, Reiko Kaji, Miyako Satouchi, et al.
Pageof 234